Russell Investments Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
2023
Q4
$37.5K Sell
2023
Q3
$133K Buy
2023
Q2
$293K Buy
2023
Q1
$182K Sell
2022
Q4
$229K Buy
2022
Q3
$317K Buy
2022
Q2
$160K Sell
2022
Q1
$246K Sell
2021
Q4
$364K Sell
2021
Q3
$574K Buy
2021
Q2
$393K Sell
2021
Q1
$633K Sell
2020
Q4
$1.03M Sell
2020
Q3
$566K Sell
2020
Q2
$807K Buy
2020
Q1
$396K Buy